Plus Pharma Senna Plus

Product NDC: 51645-850
11-digit product format: 516450850
Labeler code: 51645
Product ID: 51645-850_b3db6ed6-cbc5-d23a-e053-2995a90ad052
Type: HUMAN OTC DRUG
Nonproprietary name: DOCUSATE SODIUM,SENNOSIDES
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Gemini Pharmaceuticals, Inc. dba Plus Pharma
Application: part334
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2006-03-27
Marketing end: 2022-03-31
Substance: DOCUSATE SODIUM; SENNOSIDES
Active strength: 50 mg/1; mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	51645-850		D	Discontinued by firm	2026-08-17
excluded package	package	51645-850	51645-850-01	D	Discontinued by firm	2026-08-17
excluded package	package	51645-850	51645-850-06	D	Discontinued by firm	2026-08-17
excluded package	package	51645-850	51645-850-10	D	Discontinued by firm	2026-08-17
excluded package	package	51645-850	51645-850-99	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 60 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51645-850-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51645-850-99	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51645-850-06	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	51645-850-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51645-850-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51645-850-99	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51645-850-06	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	51645-850-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51645-850-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51645-850-99	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51645-850-06	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	51645-850-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51645-850-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51645-850-99	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51645-850-06	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	51645-850-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51645-850-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51645-850-99	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51645-850-06	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	51645-850-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51645-850-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51645-850-99	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51645-850-06	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	51645-850-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51645-850-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51645-850-99	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51645-850-06	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	51645-850-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51645-850-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51645-850-99	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51645-850-06	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	51645-850-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51645-850-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51645-850-99	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51645-850-06	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	51645-850-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51645-850-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51645-850-99	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51645-850-06	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	51645-850-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51645-850-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51645-850-99	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51645-850-06	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	51645-850-10	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51645-850-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51645-850-99	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51645-850-06	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	51645-850-10	`557ba5c1ecfa…`	`9c80585c8c6e…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51645-850-01	EA - Each	51645-850	b7c9efac-1664-4422-a6d5-192ec0c774e5	1	2021-12-08

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
SENNOSIDES	ACTIVE INGREDIENT	3FYP5M0IJX	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
DOCUSATE	ACTIVE MOIETY	M7P27195AG	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	PLUS PHARMA SENNA PLUS STANDARDIZED SENNA CONCENTRATE 8.6 MG AND DOCUSATE SODIUM 50 MG EACH (DOCUSATE SODIUM,SENNOSIDES) TABLET, FILM COATED [GEMINI PHARMACEUTICALS, INC. DBA PLUS PHARMA ]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F05Q2T2JA0	DOCUSATE SODIUM	577-11-7	DOCUSATE SODIUM
3FYP5M0IJX	SENNOSIDES		SENNOSIDES

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	9adcfb31-33b9-6b70-e053-2995a90af3eb	1
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	9adcfb31-33b9-6b70-e053-2995a90af3eb	1
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	9adcfb31-33b9-6b70-e053-2995a90af3eb	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
51645-850-06	51645085006	60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51645-850-06)	2006-03-27	2022-03-31	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Senna Plus Tablets	Gemini Pharmaceuticals, Inc. dba Plus Pharma	2020-11-11	HUMAN OTC DRUG LABEL	5
Senna Plus Tablets	medsource pharmaceuticals	2019-12-29	HUMAN OTC DRUG LABEL	1